Recall Record

Plattsburgh, NY, United States

SterRx, LLC recalls

4 recalls recorded since 2018, most recently on 7 July 2023. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)0
Terminated or completed4
Class I (FDA)1

Terminated Class II Drugs

Recall started
7 July 2023
Terminated
8 July 2024
Reason
Lack of Assurance of Sterility
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0931-2023, D-0930-2023, D-0933-2023, D-0932-2023, D-0934-2023

Terminated Class II Drugs

Recall started
25 July 2022
Terminated
22 June 2023
Reason
Lack of Assurance of Sterility
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall numbers
D-1332-2022, D-1331-2022

Terminated Class II Drugs

Recall started
12 November 2021
Terminated
6 December 2023
Reason
Lack of Assurance of Sterility
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0318-2022, D-0319-2022, D-0322-2022, D-0321-2022, D-0316-2022, D-0323-2022, D-0307-2022, D-0306-2022, D-0300-2022, D-0313-2022, D-0302-2022, D-0312-2022 and 14 more

Terminated Class I, Class II Drugs

Recall started
10 August 2021
Terminated
19 May 2022
Reason
Non-Sterility: firm's third party lab confirmed microbial contamination.
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall numbers
D-0767-2021, D-0768-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.